Skip to main content
E

Epiminder

The startup develops monitoring devices that utilize advanced neurophysiological sensors to detect and analyze epileptic seizures by capturing real-time brain activity data. This technology provides physicians with detailed insights into seizure frequency and patterns, enhancing the effectiveness of treatment plans and medication adjustments.

Melbourne, AustraliaFounded 2018271K+ followers
Updated 3 months ago

Funding

$34.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Epilepsy affects millions worldwide, and a significant percentage experience drug-resistant forms, requiring continuous and long-term monitoring of brain activity to manage the condition effectively. Traditional EEG monitoring methods often capture infrequent events, limiting the ability to provide comprehensive data for treatment planning and medication adjustments.

Solution

Epiminder offers the Minder system, an FDA-authorised implantable continuous EEG monitoring (iCEM) system designed for individuals with drug-resistant epilepsy. The system provides continuous, long-term EEG monitoring, extending the monitoring window from days to months or years, capturing infrequent events that traditional EEGs may miss. This continuous monitoring provides objective data on EEG activity, supporting drug-therapy monitoring and pre-surgical planning. The system facilitates remote monitoring, aiding in patient care and regular clinical assessment, while allowing patients to maintain their daily activities.

Target Audience

The primary target audience includes healthcare professionals and patients managing drug-resistant epilepsy who require continuous and comprehensive brain activity monitoring for effective treatment planning.

Features

  • Implantable continuous EEG monitoring (iCEM) system for long-term brain activity monitoring.
  • Extended monitoring window to capture infrequent epileptic events.
  • Objective EEG data to support drug-therapy monitoring and pre-surgical planning.
  • Remote monitoring capabilities for continuous patient care.
  • Designed to allow patients to maintain normal daily activities during monitoring.
This profile is AI-generated and may contain inaccuracies.